Average Co-Inventor Count = 12.94
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Healthcare LLC (5 from 780 patents)
2. Bayer Pharmaceuticals Corporation (2 from 70 patents)
7 patents:
1. 8829185 - Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
2. 8338595 - Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
3. 8143393 - Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
4. 8133995 - Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
5. 8129379 - Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
6. 7563791 - Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
7. 7238701 - Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders